Chris WoodAIThe paradox of AI in lung nodulesIn this column, RevealDx CEO Chris Wood describes a pathway to reducing lung cancer mortality that isn't being fully utilized in the U.S.November 24, 2025Page 1 of 1Top StoriesMolecular ImagingNew PET tracer show promise in neuroblastomaF-18 mFBG achieved a pooled sensitivity of 97%, compared with 82% for I-123 MIBG.UltrasoundAI ultrasound model accurately estimates gestational ageCTAR-guided localization may sub for CT for early-stage lung cancerCTStudy backs LDCT lung cancer screening in SingaporeClinical NewsNew criteria evaluates treatment response in bone metastases
